Results and Effects of Clinical Pharmacist Management on Postoperative Patients with Differentiated Thyroid Cancer Using Chronic Disease Man-agement System

Lin-tong LI,Cheng JI,Jian-feng SANG,Wei-hong GE
DOI: https://doi.org/10.13664/j.cnki.pcr.2017.03.025
2017-01-01
Abstract:A total of 107 differentiated thyroid cancer (DTC) patients were randomly divided into experimental group and control group. The clinical pharmacists applied the chronic disease management system to follow up the experimental group. The control group only received conventional pharmaceutical services. After one year of follow-up, the results of thyroid function compliance rate, compliance time and patient compliance of the experimental group were significantly better than those of the control group. There was no significant difference of the incidence of side effects between the two groups. Clinical pharmacists managing patients through chronic disease management system provided a new management approach for DTC patients. Individualized follow-up programs for patients significantly shortened compliance time and improved compliance rate and patient compliance.
What problem does this paper attempt to address?